Suggest Saving Ezetimibe as an Add-On in High-Risk Patients

Controversy over the role of ezetimibe (Zetia, etc) and the pros and cons of aiming for LDL goals will heat up....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote